Exploring healthcare providers practices, perspectives, and experiences CO-prescribing benzodiazepines and opioid analgesics
Ended Awarded Last action
- Contract number
- 75F40120F80519
- Awardee
-
Lake Research Partners, Inc. UEI ELJ8N6K5QNC6
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $218,064
Award facts
- Contract value 100% obligated
- $218,063.96 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 541910 Marketing Research and Public Opinion Polling
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Silver Spring, MD 20903, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Close Out | -$46,481 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $7,559 | |
| Original award | $256,985 |
About this award
The Food and Drug Administration awarded a $218,063.96 firm fixed-price delivery order to Lake Research Partners, Inc. on September 21, 2020, to explore healthcare provider practices, perspectives, and experiences regarding the co-prescribing of benzodiazepines and opioid analgesics. The contract was executed under the General Services Administration's Multiple Award Schedule and carries no set-aside designation. Work is being performed in Silver Spring, Maryland, with an ultimate completion date of June 18, 2024.
This engagement supports the FDA's broader public health mission to address concerns surrounding the concurrent use of benzodiazepines and opioids, a practice associated with significant safety risks including respiratory depression and overdose. Lake Research Partners, a research firm specializing in qualitative and quantitative analysis, is conducting what appears to be a comprehensive research initiative to inform FDA policy and healthcare provider education efforts regarding appropriate prescribing practices for these controlled substances.
Quick answers
Who was awarded contract 75F40120F80519?
75F40120F80519 was awarded to Lake Research Partners, Inc. by Food and Drug Administration (Department of Health and Human Services) on September 21, 2020.
How much is contract 75F40120F80519 worth?
The government has obligated $218,064 on 75F40120F80519.
Is contract 75F40120F80519 an order under another contract?
Yes. 75F40120F80519 is a delivery order under GS07F0027X, a federal supply schedule, on Multiple Award Schedule (MAS).
Was contract 75F40120F80519 competed?
The extent of competition for 75F40120F80519 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award